For inflammatory bowel disease research, both peptides show promise with complementary mechanisms
While alarming, theyre usually temporary, fading in 1-2 weeks
Graphical Abstract Similar content being viewed by others Background Long COVID, also referred to as post-acute sequelae of COVID-19 (PASC), is a debilitating condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, generally three months from onset, with multiorgan clinical manifestations that last for at least two months and cannot be explained by another identifiable diagnosis [1]
Ozempic and Rybelsus are formulated for type 2 diabetes
In recent years, antimicrobial peptides (AMPs) have attracted the attention of researchers
Medicine (Baltimore) 94(10):e566